Background: Interferon (IFN) is widely applied in viral hepatitis and multiple oncologic
diseases. Whereas, there is considerable controversy on how to deal with unintended …

Interferon (IFN) treatment is widely applied in viral hepatitis and multiple myeloproliferative
diseases. However, there is considerable controversy on how to deal with unintended …

BACKGROUND: Interferon alpha (IFN) is an effective treatment for a variety of conditions
including essential thrombocythemia (ET), chronic myelocytic leukemia, Hepatitis B and C …

Objective: To assess the prevalence of pregnancy and infant outcomes in interferon-beta
(IFNβ) exposed pregnant women with multiple sclerosis (MS) from European IFNβ …

Abstract Background and Objectives There is a lack of well-controlled US studies of
intramuscular (IM) interferon beta (IFNβ)-1a use in pregnant women with multiple sclerosis; …

Background: Women with multiple sclerosis (MS) are often diagnosed/treated at
childbearing age. Until recently, data on MS and interferon beta (IFNβ) exposure during …

Objective: To determine whether interferon therapy during human pregnancy increases
reproductive risks in women. Methods: This longitudinal, controlled cohort study consisted of …

Background Our aim was to estimate and compare the prevalence of adverse pregnancy
outcomes among pregnant women with multiple sclerosis (MS) exposed to interferon beta …

Background: Previous studies showed no increased risk of interferon beta use before or
early in pregnancy among women with multiple sclerosis (MS). However, knowledge about …

Objectives: To determine the prevalence of categorical measures of birth weight for
gestational age (small for gestational age (SGA), large for gestational age (LGA)), low birth …